Beer Drinking Associates with Lower Burden of Amyloid Beta Aggregation in the Brain: Helsinki Sudden Death Series

Alcoholism: Clinical and Experimental Research

Volumn 40, Issue 7, 2016, Pages 1473-1478

  Kok, Eloise H ^a   Karppinen, Toni T ^a   Luoto, Teemu ^b   Alafuzoff, Irina ^c,d,e   Karhunen, Pekka J ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UPPSALA UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alcohol Consumption; Amyloid Beta Aggregation; Beer; Spirits; Wine

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ACCIDENT; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ARTICLE; AUTOPSY; BEER; BRAIN; CARDIAC MUSCLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRINKING; GENOTYPE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN AGGREGATION; SUICIDE; WINE; ADULT; AGE; AGED; DRINKING BEHAVIOR; DRUG EFFECTS; EPIDEMIOLOGY; FINLAND; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SUDDEN DEATH;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; AUTOPSY; BEER; BRAIN; DEATH, SUDDEN; FINLAND; GENOTYPE; HUMANS; MALE; MIDDLE AGED;

EID: 84977556449     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.13102     Document Type: Article

References (40)

1. Aho L, Karkola K, Juusela J, Alafuzoff I (2009) Heavy alcohol consumption and neuropathological lesions: a post-mortem human study. J Neurosci Res 87:2786–2792.
2. Baum L, Chen L, Ng HK, Pang CP (2000) Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology. Microsc Res Tech 50:278–281.
3. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259.
4. Braak H, Braak E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351–357.
5. Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969.
6. Brust JCM (2010) Ethanol and cognition: indirect effects, neurotoxicity and neuroprotection: a review. Int J Environ Res Public Health 7:1540–1557.
7. de Bree A (2001) Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 154:150–154.
8. de Bree A, Verschuren WM, Blom HJ, Kromhout D (2001) Alcohol consumption and plasma homocysteine: what's brewing? Int J Epidemiol 30:626–627.
9. Collins MA, Neafsey EJ, Mukamal KJ, Gray MO, Parks DA, Das DK, Korthius RJ (2009) Alcohol in moderation, cardioprotection, and neuroprotection. Alcohol Clin Exp Res 33:206–219.
10. Corder E, Basun H, Lannfelt L, Viitanen M, Winblad B (1995) Apolipoprotein E-epsilon 4 gene dose. Lancet 346:967–968.
11. Cravo ML, Gloria LM, Selhub J, Nadeau MR, Camilo ME, Resende MP, Cardoso JN, Leitao CN, Mira FC (1996) Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr 63:220–224.
12. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR (1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 58:376–388.
13. Di Matteo V, Pierucci M, Di Giovanni G, Esposito E (2007) Prevention and therapy of neurodegenerative disorders: role of nutritional antioxidants, in Oxidative Stress and Neurodegenerative Disorders (Qureshi GA, Parvez SH eds), pp 621–661. Elsevier Science B.V., Amsterdam.
14. Faraco G, Park L, Zhou P, Luo W, Paul SM, Anrather J, Iadecola C (2016) Hypertension enhance Aβ-induced neurovascular dysfunction, promotes β–secretase activity, and leads to amyloidogenic processing of APP. J Cereb Blood Flow Metab 36:241–252.
15. Farrer L, Cupples L, Haines J, Hyman B, Kukull W, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. J Am Med Assoc 276:1349–1356.
16. Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT (1996) Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol 39:62–70.
17. Hillbom M (1998) Alcohol consumption and stroke: benefits and risks. Alcohol Clin Exp Res 17:281–287.
18. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548.
19. Isola J, DeVries S, Chu L, Ghazvini S, Waldman F (1994) Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145:1301–1308.
20. Karhunen PJ, Penttila A (1990) Validity of post-mortem alcohol reports. Alcohol Alcohol 25:25–32.
21. Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JCS (2004) Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache County Study. Arch Gen Psychiatry 61:518.
22. Kim YA, Lim SY, Rhee SH, Park KY, Kim CH, Choi BT, Lee SJ, Park YM, Chio YH (2006) Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells. Int J Mol Med 17:1069–1075.
23. Kok E, Haikonen S, Luoto T, Huhtala H, Goebeler S, Haapasalo H, Karhunen PJ (2009) Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol 65:650–657.
24. Kondo K (2004) Beer and health: preventive effects of beer components on lifestyle-related diseases. BioFactors 22:303–310.
25. Langballe EM, Ask H, Holmen J, Stordal E, Saltvedt I, Selbaek G, Fikseaunet A, Bergh S, Nafstad P, Tambs K (2015) Alcohol consumption and risk of dementia up to 27 years later in a large, population-based sample: the HUNT study, Norway. Eur J Epidemiol 30:1049–1056.
26. Letenneur L (2004) Risk of dementia and alcohol and wine consumption: a review of recent results. Biol Res 37:189–193.
27. Luoto TM, Haikonen S, Haapasalo H, Goebeler S, Huhtala H, Erkinjuntti T, Karhunen PJ (2009) Large vessel cerebral atherosclerosis is not in direct association with neuropathological lesions of Alzheimer's disease. Eur Neurol 62:93–98.
28. Mayer O Jr, Simon J, Rosolova H (2001) A population study of the influence of beer consumption on folate and homocysteine concentrations. Eur J Clin Nutr 55:605–609.
29. Mennen LI, de Courcy GP, Guilland JC, Ducros V, Zarebska M, Bertrais S, Favier A, Hercberg S, Galan P (2003) Relation between homocysteine concentrations and the consumption of different types of alcoholic beverages: the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr 78:334–338.
30. Panza F, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Lorusso M, Santamato A, Seripa D, Pilotto A, Scafato E, Vendemiale G, Capurso A, Solfrizzi V (2009) Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes. J Alzheimers Dis 17:7–31.
31. Panza F, Frisardi V, Seripa D, Logroscino G, Santamato A, Imbimbo BP, Scafato E, Pilotto A, Solfrizzi V (2012) Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry 27:1218–1238.
32. Polvikoski T, Sulkava R, Myllykangas L, Notkola IL, Niinisto L, Verkkoniemi A, Kainulainen K, Kontula K, Perez-Tur J, Hardy J, Haltia M (2001) Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology 56:1690–1696.
33. Sakuta H, Suzuki T, Ito T, Yasuda H (2007) Beer ethanol consumption and plasma homocysteine among patients with type 2 diabetes. Diabetes Res Clin Pract 78:202–207.
34. Saunders PA, Copeland JR, Dewey ME, Davidson IA, McWilliam C, Sharma V, Sullivan C (1991) Heavy drinking as a risk factor for depression and dementia in elderly men. Findings from the Liverpool longitudinal community study. Br J Psychiatry 159:213–216.
35. Selhub J, Troen A, Rosenberg IH (2010) B vitamins and the aging brain. Nutr Rev 68(Suppl 2):112–118.
36. Strain JJ, Dowey L, Ward M, Pentieva K, McNulty H (2004) B-vitamins, homocysteine metabolism and CVD. Proc Nutr Soc 63:597–603.
37. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800.
38. Thomas P, Fenech M (2007) A review of genome mutation and Alzheimer's disease. Mutagenesis 22:15–33.
39. de la Vega MJ, Santolaria F, Gonzalez-Reimers E, Aleman MR, Milena A, Martinez-Riera A, Gonzalez-Garcia C (2001) High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylenetetrahydrofolate reductase (MTHFR). Alcohol 25:59–67.
40. Zuccala G, Onder G, Pedone C, Cesari M, Landi F, Bernabei R, Cocchi A; Gruppo Italiano di Farmacoepidemiologia nell'Anziano Investigators (2001) Dose-related impact of alcohol consumption on cognitive function in advanced age: results of a multicenter survey. Alcohol Clin Exp Res 25:1743–1748.